Key facts
- Twin Health’s last known valuation is $950.0M (Aug 2025).
- It has raised $319.0M across 4 recorded rounds; the latest was Early Stage VC ($48.8M) in May 2025.
- Notable investors include Sequoia Capital, Peak XV Partners, Temasek Holdings, ICONIQ Growth, Benchmark Capital Holdings — 16 tracked in total.
- Twin Health has filed 5 Form Ds with the SEC since 2020, most recently May 2025 ($48.8M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Twin Health
Funding rounds
4 roundsAbout Twin Health
Developer of a precision health platform designed to measure and repair the damaged metabolism in diabetic patients. The company's platform uses artificial intelligence, the internet of things and digital technologies to understand metabolic dysfunction and measure, combines data, first-of-its-kind digital twin AI technology and insights from a clinical care team to develop a clear picture of each member's metabolism and repair the ones damaged which is the root cause of diabetes, enabling doctors to create a precision treatment for diabetic patients.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2018
- Employees
- 489
- Website
- usa.twinhealth.com/
- Ownership
- Privately Held (backing)
Twin Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Twin Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Twin Health in its N-PORT filings yet. We sweep new filings monthly.